Purpose: The aim of the study was to assess the presence and the importance of stato-kinetic dissociation (SKD) in subjects with normal and pathological visual fields (VF).

Methods: A "customized" perimetric test designed for the assessment of SKD was carried out in seven homogeneous samples of subjects (normal, glaucomatous, ocular hypertensive, retinopathic, cataract, anterior visual pathways neuropathic and posterior visual pathways neuropathic). The results were statistically compared (Anova).

Results And Conclusions: SKD is a physiological phenomenon, more evident in the central, paracentral and superior VF, influenced by age and partially by sex. SKD increases in the VF periphery when a posterior visual pathway disorder or retinopathy is present, and decreases in the centro-paracentral VF of glaucomatous and ocular hypertensive eyes. This SKD behaviour should be useful for early diagnosis of glaucoma.

Download full-text PDF

Source
http://dx.doi.org/10.1177/112067219600600412DOI Listing

Publication Analysis

Top Keywords

subjects normal
12
stato-kinetic dissociation
8
visual fields
8
glaucomatous ocular
8
ocular hypertensive
8
visual pathways
8
pathways neuropathic
8
posterior visual
8
visual
5
skd
5

Similar Publications

Background/objective: To evaluate the weight and height status of under-five children between 1992 and 2021 in relation to nutritional context.

Subjects/methods: The study is based on the lengths/heights and weights of children <5 years in five national surveys (n = 505,026). After evaluating normality of the distributions, heights, and weights were expressed as z-scores relative to the WHO reference.

View Article and Find Full Text PDF

Dual-task-related gait patterns as possible marker of precocious and subclinical cognitive alterations in Parkinson disease.

Sci Rep

January 2025

Department of Medicine, Surgery and Dentistry, Center for Neurodegenerative Diseases (CEMAND), University of Salerno, Fisciano, Italy.

Subtle gait and cognitive dysfunction are common in Parkinson's disease (PD), even before most evident clinical manifestations. Such alterations can be assumed as hypothetical phenotypical and prognostic/progression markers. To compare spatiotemporal gait parameters in PD patients with three cognitive status: cognitively intact (PD-noCI), with subjective cognitive impairment (PD-SCI) and with mild cognitive impairment (PD-MCI) in order to detect subclinical gait differences.

View Article and Find Full Text PDF

Recursive hierarchical parametric identification of Wiener-Hammerstein systems based on initial value optimization.

ISA Trans

January 2025

Institute of Artificial Intelligence and Future Networks, Beijing Normal University at Zhuhai, Zhuhai, China; BNU-HKBU United International College Tangjiawan, Rd. JinTong 2000#, Zhuhai, China. Electronic address:

In this paper, a novel recursive hierarchical parametric identification method based on initial value optimization is proposed for Wiener-Hammerstein systems subject to stochastic measurement noise. By transforming the traditional Wiener-Hammerstein system model into a generalized form, the system model parameters are uniquely expressed for estimation. To avoid cross-coupling between estimating block-oriented model parameters, a hierarchical identification algorithm is presented by dividing the parameter vector into two subvectors containing the coupled and uncoupled terms for estimation, respectively.

View Article and Find Full Text PDF

Neurofilament light chain - Can it be measured in urine?

Clin Chim Acta

January 2025

Department of Clinical Biochemistry, Aarhus University Hospital, Palle Juul Jensens Boulevard 99 8200 Aarhus N, Denmark; Department of Clinical Medicine, Aarhus University 8000 Aarhus C, Denmark.

Objective: This exploratory study investigates if neurofilament light chain (NfL) is excreted in the urine and whether this depends on plasma NfL (pNfL) levels and kidney function in terms of eGFR and U-albumin-creatinine ratio (uACR).

Methods: Using a computer algorithm, we identified excess urine and plasma from routine testing of uACR and eGFR in patients 45-50 years old. Up to 17 paired urine-plasma samples in each of six categories of kidney function defined by uACR and eGFR were analysed for NfL, and the urinary NfL-creatinine ratio (uNCR) was calculated to correct for urine dilution.

View Article and Find Full Text PDF

A Population Pharmacokinetic Analysis to Evaluate the Impact of Renal Impairment on the Pharmacokinetics of Iberdomide.

J Pharm Sci

January 2025

Clinical Pharmacology, Pharmacometrics & Bioanalysis, Bristol Myers Squibb, Princeton, NJ, USA.

Iberdomide, a novel potent cereblon E3 ligase modulator, is under investigation for multiple myeloma. This study assessed how renal impairment (RI) affects iberdomide pharmacokinetics (PK). Twenty-six subjects with varying renal function, including those with severe renal impairment and those requiring intermittent hemodialysis (IHD), received a single oral 1 mg dose of iberdomide.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!